Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NewGenGene Therapeutics
Suzhou, Jiangsu, Chinanewgengene.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
NewGenGene Therapeutics is a clinical-stage biotechnology company headquartered in Suzhou, China, specializing in the development of next-generation adeno-associated virus (AAV) gene therapies. The company leverages its proprietary NGG-AAV platform to engineer vectors with enhanced tissue specificity and reduced immunogenicity for treating rare genetic diseases and neurodegenerative conditions. Its lead candidate, NGG-101, is an AAV-based gene therapy currently undergoing Phase 1/2 clinical evaluation for Hemophilia B. Beyond hematology, NewGenGene is advancing a diverse pipeline targeting lysosomal storage disorders like Pompe disease and CNS indications such as Parkinson's disease. The firm is backed by prominent life science investors, including Qiming Venture Partners and Lilly Asia Ventures.
- Therapeutic areas
- Rare DiseasesHematologyNeurology
- Modalities
- Gene therapyBiologic
- Industry
- Biotech
Beyond the preview
Go deeper on NewGenGene Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NewGenGene Therapeutics.